Citi Raises Lexicon Pharmaceuticals (LXRX) Outlook on Strength of Novo Nordisk Partnership Milestones
Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) is one of the best fast growing penny stocks to buy according to analysts.
Lexicon Pharmaceuticals Inc. (LXRX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 38,918,903 | $44,756,738 | 1.34% | |
| 2. | Millennium Management Israel Englander | 4,821,733 | $5,544,993 | +26% | 0% |
| 3. | Sessa Capital John Petry | 3,000,000 | $3,450,000 | 0.06% | |
| 4. | Citadel Investment Group Ken Griffin | 1,710,975 | $1,967,621 | -36% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,262,367 | $1,451,722 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.32 | 133,688 | $176,468.16 | 1,654,186 | 2026-02-18 | Filing | |
| $1.31 | 76,857 | $100,544.33 | 1,520,498 | 2026-02-17 | Filing | |
| $1.31 | 57,952 | $75,876.55 | 1,443,641 | 2026-02-13 | Filing | |
| $1.30 | 1,538,462 | $2,000,000.60 | 1,538,462 | 2026-02-02 | Filing | |
| $1.05 | 90,000 | $94,797.00 | 914,359 | 2023-11-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.93 | 12,000 | $83,100.00 | 71,766 | 2021-03-15 | Filing | |
| $6.90 | 10,912 | $75,339.72 | 71,766 | 2021-03-15 | Filing | |
| $12.91 | 10,000 | $129,076.00 | 25,643 | 2018-06-08 | Filing | |
| $15.00 | 1,500 | $22,500.00 | 15,946 | 2016-06-06 | Filing | |
| $13.00 | 6,000 | $78,000.00 | 15,946 | 2016-05-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 136,180,481 | $156,607,553 | 21.91% | |
| 2. | 37,834,207 | $43,509,338 | 0% | |
| 3. | 9,606,549 | $11,047,532 | 0% | |
| 4. | 3,192,448 | $3,671,316 | 0% | |
| 5. | 3,007,237 | $3,458,322 | 0% |
News See All
7 Best Fast Growing Penny Stocks to Buy According to Analysts
On January 14, Lale Akoner, global market analyst at eToro, appeared on CNBC to state that 2026 is driven by rotation into small caps and advised diversification.
Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development
Lexicon Pharmaceuticals (NASDAQ:LXRX) is one of the fastest-growing penny stocks to buy now.
10 Fastest Growing Penny Stocks to Buy Now
Have the markets peaked? That’s the big question following a blockbuster year in which equity markets raced to record highs.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2025 Earnings Call Transcript
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2025 Earnings Call Transcript November 6, 2025Lexicon Pharmaceuticals, Inc. beats earnings expectations.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2025 Earnings Call Transcript
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2025 Earnings Call Transcript August 6, 2025Lexicon Pharmaceuticals, Inc. beats earnings expectations.
10 Hot Penny Stocks to Invest in Now
CNBC reported that consumer prices rose 2.7% year-over-year in June, suggesting that President Trump's tariffs are starting to be felt across the economy.
13 Best Multibagger Stocks to Invest in Now
The global economic and geopolitical environment in 2025 is marked by uncertainty, trade tensions, and shifting monetary policies.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Lexicon Pharmaceuticals First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Lexicon Pharmaceuticals Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center Billionaire Hedge Funds
